Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsboll T
The most frequently reported adverse effects are gastrointestinal in nature , particularly during the initial weeks of treatment or following dose increases
The drug had previously only been approved in the U.S
THE GLOW I look expensive
At the same time, payers are quietly rebelling: benefit budgets are strained, employers are pulling coverage, and policymakers are questioning how to sustain access to drugs that may be lifelong therapies for millions
Cold storage slows the natural degradation process that begins as soon as the peptide is in liquid form, extending the window during which the solution remains suitable for research use